Cytogenetics and molecular pathology in cancer diagnostics

Annals of Medicine

Volumn 36, Issue 3, 2004, Pages 162-171

  Knuutila, Sakari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cancer genetics; Chromosomal translocation; Comparative genomic hybridization; Cytogenetics; Fluorescence; Gene amplification; Gene fusion; In situ hybridization; Microarray; Molecular pathology; Polymerase chain reaction; Tyrosine kinase inhibitors

Indexed keywords

BCR ABL PROTEIN; DOXORUBICIN; GEFITINIB; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR; STEM CELL FACTOR; TRASTUZUMAB;

ACUTE GRANULOCYTIC LEUKEMIA; AMPLICON; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GENETICS; CARCINOMA; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; DNA MICROARRAY; DRUG TARGETING; EWING SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; FUSION GENE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC MARKER; GLIOMA; HEMATOLOGIC MALIGNANCY; HUMAN; IN SITU HYBRIDIZATION; LYMPHOMA; MESOTHELIOMA; MINIMAL RESIDUAL DISEASE; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MONOSOMY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NEUROBLASTOMA; NEUROGENIC TUMOR; NONHODGKIN LYMPHOMA; NONHUMAN; ONCOGENE; OVARY CARCINOMA; PATHOLOGY; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN TARGETING; REVIEW; SARCOMA;

CYTOGENETIC ANALYSIS; HUMANS; NEOPLASMS;

EID: 2342522806     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310021733     Document Type: Review

References (26)

1. Heim S, Mitelman F. Cancer Cytogenetics. 2nd edn. New-York: John Wiley & Sons, Inc; 1995.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001.
3. Tarkkanen M, Knuutila S. The diagnostic use of cytogenetic and molecular genetic techniques in the assessment of small round cell tumours. Current Diagnostic Pathology 2002;8:338-48.
4. Ottmann OG, Hoelzer D. The ABL tyrosine kinase inhibitor STI571 (Glivec) in Philadelphia positive acute lymphoblastic leukemia -promises, pitfalls and possibilities. Hematol J 2002;3:2-6.
5. Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon NB, et al. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood 1997;90:4947-52.
6. Vidgren V, Varis A, Kokkola A, Monni O, Puolakkainen P, Nordling S, et al. Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in intestinal type of gastric cancer. Genes Chromosomes Cancer 1999;24:24-9.
7. Varis A, Wolf M, Monni O, Vakkari M-L, Kokkola A, Moskaluk C, et al. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 2002;62: 2625-9.
8. El-Rifai W, Smith Jr MF, Li G, Beckler A, Carl VS, Montgomery E, et al. Gastric cancers overexpress DARPP 32 and a novel isoform, t-DARPP. Cancer Res 2002;62:4061-4.
9. Varis A, Zaika A, Puolakkainen P, Nagy B, Madrigal I, Kokkola A, et al. Coamplified and overexpressed genes at ERBB2 locus in gastric cancer. Int J Cancer 2003:in press.
10. Knuutila S, Björkqvist A-M, Autio K, Tarkkanen M, Wolf M, Monni O, et al. DNA copy number amplifications in human neoplasms. Review of comparative genomic hybridization studies. Am J Pathol 1998;152:1107-23.
11. Knuutila S, Aalto Y, Autio K, Björkqvist A-M, El-Rifai W, Hemmer S, et al. DNA copy number losses in human neoplasms. Review. Am J Pathol 1999;155:683-94.
12. Björkqvist A-M, Tammilehto L, Nordling S, Nurminen M, Anttila S, Mattson K, et al. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer 1998; 77:260-9.
13. Szymanska J, Virolainen M, Tarkkanen M, Wiklund T, Asko-Seljavaara S, Tukiainen E, et al. Overrepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study. Cancer Genet Cytogenet 1997;99:14-8.
14. Rubin I, Yarden Y. The basic biology of HER2. Ann Oncol 2001;12 (Suppl. 1):3-8.
15. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-80.
16. Heinrich M, Corless C, Duensing A, McGreevey L, Chen C-J, Joseph N, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:708-10.
17. Järvinen T, Tanner M, Rantanen V, Bärlund M, Borg Å, Grénman S, et al. Amplification and deletion of topoisomerase IIa associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am J Pathol 2000;156:839-47.
18. Baselga J, Hammond LA. HER-targeted tyrosine-kinase inhibitors. Oncology 2002;63 (Suppl. 1):6-16.
19. Jilani I, Estey E, Manshuri T, Caligiuri M, Keating M, Giles F, et al. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Leukemia 2003;17:114-9.
20. The chipping forecast II. Nat Genet 2002;32 (Suppl.):461-552.
21. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002;62: 6240-5.
22. Aalto Y, El-Rifai W, Vilpo L, Ollila J, Nagy B, Vihinen M, et al. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia 2001;15:1721-8.
23. Wikman H, Kettunen E, Seppänen JK, Karjalainen A, Hollmén J, Anttila S, et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 2002;21:5804-13.
24. Zhu Y, Hollmén J, Räty R, Aalto Y, Nagy B, Elonen E, et al. Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. Br J Haematol 2002;119:905-15.
25. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
26. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4: 844-7.